- Home
- CEAD vs SNGX Comparison
CEAD vs SNGX Comparison
Compare CEAD & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CEAD
- SNGX
- Stock Information
- Founded
- CEAD 2009
- SNGX 1987
- Country
- CEAD United States
- SNGX United States
- Employees
- CEAD N/A
- SNGX N/A
- Industry
- CEAD Industrial Machinery/Components
- SNGX Biotechnology: Pharmaceutical Preparations
- Sector
- CEAD Industrials
- SNGX Health Care
- Exchange
- CEAD Nasdaq
- SNGX Nasdaq
- Market Cap
- CEAD 5.8M
- SNGX 6.5M
- IPO Year
- CEAD N/A
- SNGX 1987
- Fundamental
- Price
- CEAD $8.04
- SNGX $1.89
- Analyst Decision
- CEAD
- SNGX
- Analyst Count
- CEAD 0
- SNGX 0
- Target Price
- CEAD N/A
- SNGX N/A
- AVG Volume (30 Days)
- CEAD 6.2K
- SNGX 18.7K
- Earning Date
- CEAD 05-15-2025
- SNGX 05-09-2025
- Dividend Yield
- CEAD N/A
- SNGX N/A
- EPS Growth
- CEAD N/A
- SNGX N/A
- EPS
- CEAD N/A
- SNGX N/A
- Revenue
- CEAD $3,282,424.00
- SNGX $2,342.00
- Revenue This Year
- CEAD N/A
- SNGX N/A
- Revenue Next Year
- CEAD N/A
- SNGX N/A
- P/E Ratio
- CEAD N/A
- SNGX N/A
- Revenue Growth
- CEAD 33.28
- SNGX N/A
- 52 Week Low
- CEAD $5.60
- SNGX $1.68
- 52 Week High
- CEAD $12.26
- SNGX $14.83
- Technical
- Relative Strength Index (RSI)
- CEAD 55.51
- SNGX 45.39
- Support Level
- CEAD $7.51
- SNGX $1.85
- Resistance Level
- CEAD $7.24
- SNGX $1.95
- Average True Range (ATR)
- CEAD 0.30
- SNGX 0.09
- MACD
- CEAD 0.16
- SNGX 0.01
- Stochastic Oscillator
- CEAD 80.46
- SNGX 42.11
About CEAD CEA Industries Inc.
CEA Industries Inc through its subsidiary is focused on selling environmental control and other technologies and services to the Controlled Environment Agriculture ("CEA") industry. The company provides integrated mechanical, electrical, and plumbing ("MEP") engineering design, proprietary and curated environmental control equipment, and automation offerings that serve the CEA industry. The Company has one operating segment that is dedicated to the manufacture and sale of its products.
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).